<DOC>
	<DOCNO>NCT02675257</DOCNO>
	<brief_summary>This randomise controlled trial evaluate cognitive-behavioural intervention diabetes patient suboptimal glycaemic control comorbid depressive symptom and/or diabetes distress . The main outcome improvement suboptimal glycaemic control ( HbA1c ) . Secondary outcome effect depressive symptom , diabetes distress , self-care behaviour , diabetes acceptance quality life . The treatment group treat cognitive-behavioural group treatment comprise specific intervention improve glycaemic control reduce diabetes distress well depressive symptom . The control group receive treatment-as-usual . A total 212 study participant include . A secondary study objective analyse association suboptimal glycaemic control , depressive symptom diabetes distress inflammatory marker .</brief_summary>
	<brief_title>Depression Diabetes Control Trial</brief_title>
	<detailed_description>Suboptimal glycaemic control establish risk factor development serious long-term complication diabetes . Moreover , associate elevated risk significant hyperglycaemic acute event hyperosmolar hyperglycemic state diabetic ketoacidosis . Hence , patient diabetes persistent suboptimal glycaemic control high risk rather poor prognosis . Besides physiological medical factor , psychological problem find predict suboptimal glycaemic control . A number study find depressive symptom independently associate hyperglycaemia . Others focus diabetes-specific affective problem - call diabetes distress - suggested factor great importance . Finally , study find depressive symptom diabetes distress may interact , coocurrence factor associate high risk suboptimal glycaemic control . The result correspond finding suggest depressive symptom diabetes distress often associate reduce diabetes self-care , explain association factor hyperglycaemia . On hand , suboptimal glycaemic control could also explanation affective problem - either mediate physiological mechanism psychological one , e.g . dissatisfaction guilt . Hence , valid assume link depressive symptom and/or diabetes distress may bidirectional - although evidence support assumption miss . Following evidence background , investigator design analyse relationship suboptimal glycaemic control , depressive symptom diabetes distress diabetes use prospective study design . The study randomize trial cognitive-behavioural group treatment compare treatment-as-usual condition ( standard diabetes education ) regard efficacy improve suboptimal glycaemic control . 212 diabetes patient suboptimal glycaemic control ( HbA1c value &gt; 7.5 % ) elevate depressive symptom ( Center Epidemiologic Studies Depressions Scale score ≥ 16 ) and/or elevate diabetes distress ( Problem Areas In Diabetes Scale score ≥ 40 ) randomly assign either treatment group treatment-as-usual . The primary outcome improvement suboptimal glycaemic control ( reduction HbA1c ) 12-month follow-up . As secondary outcome positive baseline-to-follow change regard depressive symptom , diabetes distress , diabetes self-care behaviour , diabetes acceptance quality life assess . A second study objective analyse cross-sectional prospective association suboptimal glycaemic control , depressive symptom diabetes distress serum level follow inflammatory marker : hsCRP , IL-6 , IL-18 , IL-1Ra , MCP-1 Adiponectin . Potential effect treatment group marker also examine .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Age 18 70 Diabetes mellitus type 1 type 2 Diabetes duration ≥ 1 year Suboptimal glycaemic control ( HbA1c &gt; 7,5 % ) Elevated depressive symptom ( CESD score ≥ 16 ) and/or elevate diabetes distress ( PAID score ≥ 40 ) Sufficient language skill Written inform consent Severe major depressive disorder accord ICD10 Current psychiatric and/or psychotherapeutic treatment Current antidepressive medical treatment Suicidal ideation Acute mental disorder follow type : schizophrenia psychotic disorder , bipolar disorder , severe eat disorder ( anorexia nervosa , bulimia nervosa ) , substance use disorder History personality disorder Severe somatic illness : dialysisdependent nephropathy , acute cancer , severe heart disease ( NYHA III IV ) , severe neurologic illness ( e. g. MS , dementia ) , severe autoimmune disease Terminal illness Bedriddenness Guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Affective disorder</keyword>
	<keyword>Depressive symptom</keyword>
	<keyword>Diabetes distress</keyword>
	<keyword>Hyperglycaemia</keyword>
	<keyword>Dysglycaemia</keyword>
	<keyword>Glycaemic control</keyword>
	<keyword>Self-care behaviour</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Diabetes acceptance</keyword>
	<keyword>Diabetes complication</keyword>
	<keyword>Low-grade inflammation</keyword>
	<keyword>Inflammatory marker</keyword>
	<keyword>Stress reactivity</keyword>
	<keyword>Health-care cost</keyword>
</DOC>